NetworkNewsBreaks – Predictive Oncology Inc. (NA
Post# of 281
(Total Views: 140)
Posted On: 09/20/2019 5:35:27 PM
NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Transforming Cancer-Treatment Outcomes via Proprietary Database
Predictive Oncology (NASDAQ: POAI) is taking a unique approach to cancer treatment by utilizing its proprietary database of cancer cases using the proven power of artificial intelligence (“AI”). A recent article discussing the company reads, “The company works alongside pharmaceutical, diagnostic and biotechnology industry players to develop highly customizable assessment methods that can be applied to both individualize current therapies and develop the next generation of precision therapies, leading to better outcomes for patients. The company recently announced a corporate name change from Precision Therapeutics to Predictive Oncology Inc., which reflects its mission and strategic emphasis. . . . Predictive Oncology seeks to revolutionize the way cancer is treated for both the patients of today and those of tomorrow. The company is well positioned to do exactly that as a result of two key assets: its ability to grow patients’ own tumors in the laboratory and test the tumors’ responses to chemotherapy, together with its existing database of outcome data cataloguing more than 150,000 tumors and their specific responses to those chemotherapies.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Predictive Oncology (NASDAQ: POAI) is taking a unique approach to cancer treatment by utilizing its proprietary database of cancer cases using the proven power of artificial intelligence (“AI”). A recent article discussing the company reads, “The company works alongside pharmaceutical, diagnostic and biotechnology industry players to develop highly customizable assessment methods that can be applied to both individualize current therapies and develop the next generation of precision therapies, leading to better outcomes for patients. The company recently announced a corporate name change from Precision Therapeutics to Predictive Oncology Inc., which reflects its mission and strategic emphasis. . . . Predictive Oncology seeks to revolutionize the way cancer is treated for both the patients of today and those of tomorrow. The company is well positioned to do exactly that as a result of two key assets: its ability to grow patients’ own tumors in the laboratory and test the tumors’ responses to chemotherapy, together with its existing database of outcome data cataloguing more than 150,000 tumors and their specific responses to those chemotherapies.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Predictive Oncology Inc. (POAI) Stock Research Links
Scroll down for more posts ▼